These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11737894)

  • 1. Reasons for hope: Canadian Breast Cancer Research Conference, Le Concorde Hotel, Quebec City, Quebec, Canada, 3-5 May 2001.
    Roskelley C
    Breast Cancer Res; 2001; 3(6):404-6. PubMed ID: 11737894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the National Workshop on Research Methodologies for Unconventional Therapies, sponsored by the Canadian Breast Cancer Research Initiative (CBCRI), held October 4-6, 1996, at the Delta Pacific Resort and Conference Center in Richmond, B.C.
    Jacobson JS
    J Altern Complement Med; 1996; 2(4):541-4. PubMed ID: 9395685
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers.
    Larouche G; Chiquette J; Plante M; Pelletier S; Simard J; Dorval M
    Can Assoc Radiol J; 2016 Nov; 67(4):308-312. PubMed ID: 27318890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 Apr; 158(7):897-902. PubMed ID: 9559016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 14th International TNF Conference, Québec City, Canada - Des Progrės Récents aux Défis Futurs (Recent Advances toward Future Challenges).
    Burkly L; Gommerman JL
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):77-81. PubMed ID: 24698109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research, practice, and policy partnerships in pan-Canadian coalitions for cancer and chronic disease prevention.
    Manafò E; Petermann L; Lobb R; Keen D; Kerner J
    J Public Health Manag Pract; 2011; 17(6):E1-E11. PubMed ID: 21964372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference on plant-made pharmaceuticals. 16-19 March 2003, Québec City, Québec, Canada.
    Price B
    IDrugs; 2003 May; 6(5):442-5. PubMed ID: 12841207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFOMPT 2012: a rendez-vous of hands and minds.
    Werstine R; Chesworth BM
    J Orthop Sports Phys Ther; 2012 Oct; 42(10):A1-A83. PubMed ID: 23023241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 70th Annual Meeting of the Canadian Rheumatology Association, Quebec City, Quebec, Canada, February 4-7, 2015.
    Silverman ED
    J Rheumatol; 2015 May; ():. PubMed ID: 25979717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health services research in breast cancer: background paper for a Canadian Breast Cancer Research Initiative workshop.
    Goel V
    Cancer Prev Control; 1998 Aug; 2(4):173-8. PubMed ID: 10093630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2005 conference on the biology of manual therapies.
    Khalsa PS; Eberhart A; Cotler A; Nahin R
    J Manipulative Physiol Ther; 2006 Jun; 29(5):341-6. PubMed ID: 16762659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
    Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD
    Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics, eh! A meeting summary of the Canadian Conference on Epigenetics.
    Rodenhiser DI; Bérubé NG; Mann MR
    Epigenetics; 2011 Oct; 6(10):1265-71. PubMed ID: 21931277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From heart health promotion to chronic disease prevention: contributions of the Canadian Heart Health Initiative.
    Robinson K; Farmer T; Elliott SJ; Eyles J
    Prev Chronic Dis; 2007 Apr; 4(2):A29. PubMed ID: 17362620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carbon footprint cost of travel to Canadian Urological Association conferences.
    Vanin Moreno NM; Paco C; Touma N
    Can Urol Assoc J; 2023 Jun; 17(6):E172-E175. PubMed ID: 36952297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the path to translation: Highlights from the 2010 Canadian Conference on Ovarian Cancer Research.
    Thériault BL; Shepherd TG
    J Ovarian Res; 2011 Jun; 4():10. PubMed ID: 21699706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada.
    Lemieux J; Audet S
    Curr Oncol; 2018 Jun; 25(Suppl 1):S161-S170. PubMed ID: 29910659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting equitable global health research: a policy analysis of the Canadian funding landscape.
    Plamondon K; Walters D; Campbell S; Hatfield J
    Health Res Policy Syst; 2017 Aug; 15(1):72. PubMed ID: 28851388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11th International Conference on Neuroprotective Agents, Wendake, Quebec City, Quebec, Canada, Sept 30-Oct 3, 2012.
    Sharma HS; Sharma A; Skaper S
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):951-2. PubMed ID: 23244422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.